Zentalis Pharmaceuticals (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- December 09, 2019
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $85,000,000
Company Info
- Founders
- Anthony Sun
- Company Description
- Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
- Market
- Oncology
- Location
- New York, NY, USA
- Coinvestors
- Eventide Asset Management, Farallon Capital Management, Matrix Capital Management, Perceptive Advisors, Redmile Group, Surveyor Capital, Viking Global Investors